SCHEMBL8377010

SCHEMBL8377010

COc1cc2c(N3CCC(N(C)C)CC3)ncnc2c(OC)c1OC

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 2/20 0.48
▸ ENPP1 P22413 4/20 0.46
▸ PDE1B Q01064 3/20 0.45
▸ HRH4 Q9H3N8 1/20 0.43
▸ ACHE P22303 2/20 0.43
▸ BACE1 P56817 2/20 0.43
▸ PDE10A Q9Y233 3/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ JAK1 P23458 1/20 0.43
▸ JAK3 P52333 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ CCR4 P51679 1/20 0.41
▸ PDE3B Q13370 1/20 0.41
▸ PDE3A Q14432 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8374707 0.99 PDE5A (0.47) PDE5AENPP1PDE1BHRH4ACHE
SCHEMBL8374536 0.85 PDE5A (0.50) PDE5AENPP1PDE1BACHEBACE1
Hydrochloric Acid SCHEMBL8379494 0.82 PDE5A (0.55) PDE5AENPP1PDE1BACHEBACE1
SCHEMBL8378420 0.81 NEK2 (0.53) PDE5AENPP1PDE1BACHEBACE1
Hydrochloric Acid SCHEMBL8375179 0.81 PDE5A (0.54) PDE5AENPP1PDE1BACHEBACE1
Hydrochloric Acid SCHEMBL8375907 0.81 TLR9 (0.47) PDE5AENPP1PDE1BACHEBACE1
SCHEMBL8374694 0.81 KDM4E (0.65) PDE5AENPP1PDE1BACHEBACE1
SCHEMBL2920637 0.80 PDE5A (0.52) PDE5AENPP1PDE1BACHEBACE1
SCHEMBL8374872 0.79 PDE5A (0.51) PDE5AENPP1PDE1BACHEBACE1
Hydrochloric Acid SCHEMBL8375906 0.79 PDE10A (0.64) PDE5APDE1BACHEBACE1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990117-A Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives CELL PATHWAYS, INC. (US) 1999-11-23 — — US disclosed
US-5614627-A Quinazoline compounds EISAI CO., LTD. (JP) 1997-03-25 — — US disclosed
EP-0669324-A1 QUINAZOLINE COMPOUND Eisai Co., Ltd. (JP) 1995-08-30 — — EP disclosed
Send feedback